William H. Collier's most recent trade in Arbutus Biopharma Corp was a trade of 866,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arbutus Biopharma Corp | William H. Collier | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 866,000 | 866,000 | - | - | Stock Option (Right to Buy) | |
| Arbutus Biopharma Corp | William H. Collier | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 216,500 | 216,500 (0%) | 0% | 0 | Common Shares | |
| Arbutus Biopharma Corp | William H. Collier | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 787,550 | 787,550 | - | - | Stock Option (Right to Buy) | |
| Arbutus Biopharma Corp | William H. Collier | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2021 | 675,000 | 675,000 | - | - | Stock Options | |
| Arbutus Biopharma Corp | William H. Collier | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2020 | 70,000 | 70,000 | - | - | Stock Options |